273 related articles for article (PubMed ID: 25676433)
1. Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma.
Chevinsky M; Imnadze M; Sankin A; Winer A; Mano R; Jakubowski C; Mashni J; Sjoberg DD; Chen YB; Tickoo SK; Reuter VE; Hakimi AA; Russo P
J Urol; 2015 Aug; 194(2):310-5. PubMed ID: 25676433
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
3. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
[TBL] [Abstract][Full Text] [Related]
4. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
[TBL] [Abstract][Full Text] [Related]
7. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
[TBL] [Abstract][Full Text] [Related]
8. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
[TBL] [Abstract][Full Text] [Related]
9. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
[TBL] [Abstract][Full Text] [Related]
10. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
[TBL] [Abstract][Full Text] [Related]
11. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
[TBL] [Abstract][Full Text] [Related]
12. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
13. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification].
Utsunomiya N; Kono Y; Matsumoto K; Sumiyoshi T; Masuda N; Shiraishi Y; Negoro H; Tsunemori H; Sugino Y; Okubo K; Okada T; Segawa T; Muguruma K; Kawakita M
Hinyokika Kiyo; 2014 Jan; 60(1):1-5. PubMed ID: 24594765
[TBL] [Abstract][Full Text] [Related]
15. Pathological stage does not alter the prognosis for renal lesions determined to be stage T1 by computerized tomography.
Roberts WW; Bhayani SB; Allaf ME; Chan TY; Kavoussi LR; Jarrett TW
J Urol; 2005 Mar; 173(3):713-5. PubMed ID: 15711249
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
18. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors and oncological outcomes of pathological T3a upstaging in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
Ishiyama R; Omae K; Kondo T; Iizuka J; Yoshida K; Fukuda H; Tachibana H; Ishihara H; Kobayashi H; Takagi T
Jpn J Clin Oncol; 2024 Feb; 54(2):160-166. PubMed ID: 37840320
[TBL] [Abstract][Full Text] [Related]
20. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
